Franklin Resources Inc Morpho Sys Ag Transaction History

Franklin Resources Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$30.28 - $35.72 $15.7 Million - $18.6 Million	-520,010 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$24.08 - $33.35 $1.61 Million - $2.23 Million	-66,990 Reduced 11.41%	520,010 $18.2 Million
Q1 2020 May 13, 2020	SELL	$18.86 - $37.36 $1.56 Million - $3.09 Million	-82,800 Reduced 12.36%	587,000 $14.4 Million
Q4 2018 Feb 12, 2019	SELL	$21.96 - $31.02 $4.98 Million - $7.04 Million	-226,863 Reduced 25.3%	669,800 $16.9 Million
Q3 2018 Nov 13, 2018	SELL	$26.64 - $35.66 $1.52 Million - $2.03 Million	-56,939 Reduced 5.97%	896,663 $23.9 Million
Q2 2018 Aug 14, 2018	BUY	$25.15 - $30.6 $24 Million - $29.2 Million	953,602 New	953,602 $28.9 Million

1.8M

14.7K

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.